跳至主要内容
临床试验/JPRN-UMIN000005489
JPRN-UMIN000005489已完成未知

Effect of Pitavastatin on the coronary endothelial dysfunction after PCI with DES (Drug-eluting stent) - Effect of Pitavastatin on the coronary endothelial dysfunction after PCI with DES (Drug-eluting stent)

Hiroshima University hospital0 个研究点目标入组 30 人开始时间: 2011年4月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.A PCI target lesion with graft disease or in-stent restenosis 2.Patients who have skip lesion without PCI target lesion, and planed PCI within this examination. But it does not limit the PCI by a disease of the right coronary artery 3.Stent which is BMS to use for PCI 4.Malignant tumor in active phase 5.Patients who meet contraindication of LIVALO tablet below a)Patients who have hypersensitivity to LIVALO tablet b)Patients who have severe liver dysfunction or biliary atresia c)Patients who are being treated with cyclosporine d)Pregnant women, women suspected of being pregnant, or lactating women 6.Patients with hypersensitive to contrast media 7.Patients with liver dysfunction [ALT(GPT) 100 IU/L <=] 8.Patients undergoing dialysis 9.Patients with familial hypercholesterolemia 10.Patients who are ineligible in the opinion of the investigator

研究者

相似试验